Published in Proc Natl Acad Sci U S A on November 13, 2001
Rapid changes in gene expression direct rapid shifts in intestinal form and function in the Burmese python after feeding. Physiol Genomics (2015) 0.77
Alternative form of glucose-dependent insulinotropic polypepide and its physiology. J Diabetes Investig (2016) 0.75
Growth and stress response mechanisms underlying post-feeding regenerative organ growth in the Burmese python. BMC Genomics (2017) 0.75
Absence of exendin-4 effects on postprandial glucose and lipids in the Gila monster, Heloderma suspectum. J Comp Physiol B (2006) 0.75
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia (1972) 2.63
A vertebrate model of extreme physiological regulation. Nature (1998) 2.10
Adaptive responses to feeding in Burmese pythons: pay before pumping. J Exp Biol (1995) 1.63
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept (1984) 1.11
Determinants of the postfeeding metabolic response of Burmese pythons, Python molurus. Physiol Zool (1997) 1.07
Tachykinins (substance P, neurokinin A and neuropeptide gamma) and neurotensin from the intestine of the Burmese python, Python molurus. Peptides (1997) 0.85
Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Dig Dis Sci (1985) 0.85
Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery. Am J Surg (1993) 0.84
Luminal and systemic signals trigger intestinal adaptation in the juvenile python. Am J Physiol Gastrointest Liver Physiol (2000) 0.82
Postnatal development of circulating cholecystokinin and secretin, pancreatic growth, and exocrine function in guinea pigs. Int J Pancreatol (1993) 0.80
Fasting and postprandial GIP values in pigs, rats, dogs, and man measured with five different GIP antisera. Scand J Gastroenterol (1984) 0.80
Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter. Surgery (1992) 0.79
Purification and characterization of islet hormones (insulin, glucagon, pancreatic, polypeptide and somatostatin) from the Burmese python, Python molurus. Regul Pept (1997) 0.78
Route of passive ion permeation in epithelia. Nat New Biol (1972) 4.78
Maximal sustained energy budgets in humans and animals. Nature (1997) 4.06
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Dinosaurs, dragons, and dwarfs: the evolution of maximal body size. Proc Natl Acad Sci U S A (2001) 2.80
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Conjugated polyene fatty acids on fluorescent probes: spectroscopic characterization. Biochemistry (1977) 2.19
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
A vertebrate model of extreme physiological regulation. Nature (1998) 2.10
Outpatient management of small traumatic hyphaemas: is it safe? Eye (Lond) (1993) 2.07
'Alternative cancer cures': looking for common ground. Lancet Oncol (2000) 1.95
Possible role for cyclic GMP in endothelium-dependent relaxation of rabbit aorta by acetylcholine. Comparison with nitroglycerin. Res Commun Chem Pathol Pharmacol (1983) 1.93
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Pertussis immunisation and serious acute neurological illnesses in children. BMJ (1993) 1.71
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Measles vaccination and neurological events. Lancet (1997) 1.66
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry (2000) 1.63
Adaptive responses to feeding in Burmese pythons: pay before pumping. J Exp Biol (1995) 1.63
Times to extinction for small populations of large birds. Proc Natl Acad Sci U S A (1993) 1.62
Professional satisfaction and dissatisfaction of family physicians. J Fam Pract (1993) 1.61
Sustained metabolic scope. Proc Natl Acad Sci U S A (1990) 1.59
Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58
The activation and distribution of GABA and L-glutamate receptors on goldfish Mauthner neurones: an analysis of dendritic remote inhibition. J Physiol (1968) 1.57
Metabolic rate and environmental productivity: well-provisioned animals evolved to run and idle fast. Proc Natl Acad Sci U S A (2001) 1.49
Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am J Physiol (1992) 1.43
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology (1988) 1.40
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas (2000) 1.33
Regulation of intestinal sugar transport. Physiol Rev (1997) 1.32
Effect of catecholamines on smooth muscle motility and phosphorylase activity. J Pharmacol Exp Ther (1966) 1.32
Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology (1986) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Blockade of the biochemical correlates of contraction and relaxation in uterine and intestinal smooth muscle. Ann N Y Acad Sci (1967) 1.31
An automated machine vision system for the histological grading of cervical intraepithelial neoplasia (CIN). J Pathol (2000) 1.28
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Genetic and phenotypic adaptation of intestinal nutrient transport to diet in fish. J Physiol (1987) 1.23
Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand (1985) 1.21
Regulatory peptides in the mammalian respiratory tract. Endocrinology (1982) 1.21
Nutrient extraction by cold-exposed mice: a test of digestive safety margins. Am J Physiol (1991) 1.21
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Evidence that axoplasmic transport of trophic factors is involved in the regulation of peripheral nerve fields in salamanders. J Physiol (1973) 1.19
Gut hormone release after intestinal resection. Gut (1982) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
Trophic regulation of nerve sprouting. Science (1976) 1.16
Peptidergic innervation of the human male genital tract. J Urol (1983) 1.16
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology (1991) 1.15
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology (1983) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil (2009) 1.14
Is mammary output capacity limiting to lactational performance in mice? J Exp Biol (1996) 1.14
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 1.12
Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. Mol Pharmacol (1976) 1.11
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
Smooth muscle relaxants: dissociation between resting membrane potential and resting tension in rat myometrium. J Pharmacol Exp Ther (1969) 1.11
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol (2004) 1.10
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica (2001) 1.10
Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) (1985) 1.10
Paracellular glucose transport plays a minor role in the unanesthetized dog. Am J Physiol (1999) 1.09
Analysis of Mauthner cell responses to iontophoretically delivered pulses of GABA, glycine and L-glutamate. J Physiol (1973) 1.08
Evaluation of kemptide, a synthetic serine-containing heptapeptide, as a phosphate acceptor for the estimation of cyclic AMP-dependent protein kinase activity in respiratory tissues. Biochem Pharmacol (1990) 1.07
Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry (1984) 1.07
Determinants of the postfeeding metabolic response of Burmese pythons, Python molurus. Physiol Zool (1997) 1.07
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Lack of correlation between cyclic GMP elevation and relaxation of nonvascular smooth muscle by nitroglycerin, nitroprusside, hydroxylamine and sodium azide. J Pharmacol Exp Ther (1983) 1.06
Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci (2008) 1.06
Pancreatic tumours produce neurotensin. J Clin Endocrinol Metab (1981) 1.05
Role of cyclic nucleotides in control of smooth muscle contraction. Adv Cyclic Nucleotide Res (1978) 1.05
Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res (2000) 1.05
Evidence that endogenous beta nerve growth factor is responsible for the collateral sprouting, but not the regeneration, of nociceptive axons in adult rats. Proc Natl Acad Sci U S A (1987) 1.04
Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. J Physiol (1983) 1.04
In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J Surg Res (1998) 1.04
Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol Pharmacol (1991) 1.03
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer (2008) 1.03
Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology (2001) 1.02
The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J Comp Neurol (1984) 1.02
Crypt-villus site of glucose transporter induction by dietary carbohydrate in mouse intestine. Am J Physiol (1992) 1.02
Effect of meal composition and sham feeding on duodenojejunal motility in humans. Dig Dis Sci (1992) 1.02
Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg (1996) 1.01
Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology (1983) 1.01
The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol Metab (2000) 1.00
Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man. Eur J Clin Invest (1979) 1.00
The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. Clin Sci (Lond) (1983) 1.00